Abstract

Human platelet alpha 2-adrenergic receptors have been purified approximately 80,000-fold to apparent homogeneity by a five-step chromatographic procedure. The overall yield starting from the membranes is approximately 2%. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of radioiodinated protein from purified receptor preparations shows a single major band of Mr 64,000. The specific binding activity of the alpha 2-adrenergic receptor after four chromatographic steps is 14.5 nmol/mg protein. This value is consistent with the expected theoretical specific activity (15.6 nmol/mg) for a protein with a molecular mass of 64,000 daltons if it is assumed that there is one ligand-binding site/receptor molecule. The purified protein can be covalently labeled with the alkylating alpha-adrenergic ligand, [3H]phenoxybenzamine. This labeling is specific, and it shows that the Mr 64,000 protein contains the ligand binding site of the alpha 2-adrenergic receptor. In addition, the competitive binding of ligands to the purified receptor protein shows the proper alpha 2-adrenergic specificity. The alpha 2-adrenergic receptor contains an essential sulfhydryl residue. Thus, exposure of the purified receptor to the sulfhydryl-specific reagent, phenylmercuric chloride, resulted in an 80% loss of binding activity. This loss of binding activity was prevented when exposure to phenylmercuric chloride was done in the presence of alpha 2-adrenergic ligands, and it was reversed by subsequent exposure to dithiothreitol. Partial proteolysis of purified alpha 2-adrenergic receptors was obtained with Staphylococcus aureus V-8 protease, alpha-chymotrypsin, and papain. In a comparison with purified beta 2-adrenergic receptors, no common partial proteolytic products were found.

Highlights

  • [ 3 H ] p h e n ~ ~ y b e n ~aac-etylcholine, the D-2 dopamine, the opiate, andthe A-1 mine

  • M r 64,000 protein contains the ligand bindingsite of The inhibition of adenylate cyclase is initiated by an apparent the a2-adrenergic receptor

  • Several guanine nucleotidephenylmercuric chloride was done in the presence of binding proteins that may be involved in the inhibition of az-adrenergic ligands, and it was reversed by subse- adenylate cyclase havebeen identified and purified [5,6,7,8]

Read more

Summary

Overall purification

Membranes* Soluble' 1st A25ff.6inity 1st He2p3a4rin WGA 2nd Affinity 2n2d2.6Heparin ml. During the first heparin-agarose chromatography step, was a significant 10-15-fold purification achieved, but the receptor binding activity was substantially concentrated. The second heparin-agarose chromatography step was usefulfor the concentration of binding activity and itwas necessary for the complete purification of the az-adrenergicreceptor. Purification of the receptor was necessaryat this stage of the purification, significant increases in the specific binding activity were not documented; based upon the results of SDS-PAGE, the second heparin chromatography step was useful for the removal of two apparently contaminating proteins (cf Fig. 4, Miniprint Section and Fig. 5). The nature of the M , 80,000 and the M , 54,000 proteins which are present following the second affinity chromatography step is unknown (see Fig. 4, MiniprintSection) The evidence that they tendto copurify suggests that they may be structurally or functionally related to thea2-adrenergicreceptor.

MINIPRINT SECTION
EXPERIMENTAL PROCEDURES
For membrane preparations bound and free
In developing the purification procedure phentolamiwnaes found to have
Electrophoresis was performed as
RESULTS
Digitonin to ProteinRatio
An unexpectedfinding was that thepresenceof
PHEN PAC APLRPAZ
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call